Antipsychotic withdrawal-induced relapse predicts future relapses in institutionalized adults with severe intellectual disability / David S. Janowsky en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 4 (Agosto) . - pp. 401-405 Título : Antipsychotic withdrawal-induced relapse predicts future relapses in institutionalized adults with severe intellectual disability Tipo de documento: texto impreso Autores: David S. Janowsky, Autor ; L. Jarrett Barnhill, Autor ; Abdul S. Khalid, Autor Fecha de publicación: 2023 Artículo en la página: pp. 401-405 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Institucionalización, Discapacidad Intelectual, Síndrome de abstinencia de sustancias. Resumen: Severe intellectual and developmental disabilities are frequently associated with aggression toward self and others, destruction of property, and disruption. Antipsychotic medications are a mainstay of treatment of such behaviors. National and state guidelines suggest stopping these medications or decreasing their dosages when possible if patients have maintained stability. Link: ./index.php?lvl=notice_display&id=30839 [artículo] Antipsychotic withdrawal-induced relapse predicts future relapses in institutionalized adults with severe intellectual disability [texto impreso] / David S. Janowsky, Autor ; L. Jarrett Barnhill, Autor ; Abdul S. Khalid, Autor . - 2023 . - pp. 401-405. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 4 (Agosto) . - pp. 401-405 Palabras clave: Antipsicóticos, Institucionalización, Discapacidad Intelectual, Síndrome de abstinencia de sustancias. Resumen: Severe intellectual and developmental disabilities are frequently associated with aggression toward self and others, destruction of property, and disruption. Antipsychotic medications are a mainstay of treatment of such behaviors. National and state guidelines suggest stopping these medications or decreasing their dosages when possible if patients have maintained stability. Link: ./index.php?lvl=notice_display&id=30839

---

1 (1 - 1 / 1)